Thank you to all the witnesses for attending. It's very interesting and there's not enough time to do justice to all of you.
I want to start, if I can, with Mr. Robinson and Mr. Fleming of the Research-Based Pharmaceutical Companies.
You say in your brief that Canada secures less than 1% of global R and D from the innovative pharmaceutical industry despite being a global leader. You're asking, it seems, for more federal funding despite being part of what I would have thought was a very profitable sector. Do you have suggestions for how we can get increased R and D in this country? How can the federal government be a driver of scientific innovation? Is it simply a question of adding more money from the federal government? What are your suggestions?